Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals plc (JAZZ), sold 14,318 shares at $168.26 ($2.4M) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($2.4M) by EVP, Global Head of R&D & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $168.26 | 7,159 | $1.2M | 50.0% |
| 2 | $168.26 | 7,159 | $1.2M | 50.0% |
| Total | $168.26 avg | 14,318 | $2.4M | 100% |
| Filing → |
| JAZZ | SELL | 2025-03-07 | $1.7M | — | Filing → |
| JAZZ | SELL | 2022-12-13 | $559K | — | Filing → |